Mesoblast (MESO) EBT Growth (1y) (2015 - 2023)
Mesoblast (MESO) EBT Growth (1y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -2.10% |
| Mar 31, 2023 | 12.65% |
| Dec 31, 2022 | 5.64% |
| Sep 30, 2022 | 25.40% |
| Jun 30, 2022 | 2.79% |
| Mar 31, 2022 | 19.79% |
| Dec 31, 2021 | -1.59% |
| Sep 30, 2021 | 10.16% |
| Jun 30, 2021 | 38.31% |
| Mar 31, 2021 | -54.56% |
| Dec 31, 2020 | 4.60% |
| Sep 30, 2020 | -240.80% |
| Jun 30, 2020 | -50.05% |
| Mar 31, 2020 | 36.64% |
| Dec 31, 2019 | 2.24% |
| Sep 30, 2019 | 63.30% |
| Jun 30, 2019 | -9.37% |
| Mar 31, 2019 | -10.63% |
| Dec 31, 2018 | -184.98% |
| Sep 30, 2018 | -103.72% |